generics

Novartis cancels $1B sale of generics after antitrust concerns forced delays
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Novartis
generics
Sandoz
antitrust
Flag link:
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss
Fierce Pharma
Amarin
Vascepa
generics
patents
Flag link:
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
AbbVie will allow generic copies of its HIV pill in Israel after the government approved a license
Stat
AbbVie
Kaletra
generics
Israel
COVID-19
Flag link:
Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports
Drugmaker rethinks its decision to double price of a generic after Trump calls it a coronavirus lifesaver — reports
Endpoints
Donald Trump
COVID-19
generics
Rising Pharmaceuticals
drug pricing
chloroquine phosphate
Flag link:
Coronavirus spurs India to restrict exports of 2 dozen drugs
Coronavirus spurs India to restrict exports of 2 dozen drugs
Fierce Pharma
generics
India
coronavirus
COVID-19
Flag link:
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Sandoz
generics
Novartis
antitrust
Flag link:
The FDA OKs generic Daraprim, the Martin Shkreli therapy that triggered an unending tempest over drug pricing
The FDA OKs generic Daraprim, the Martin Shkreli therapy that triggered an unending tempest over drug pricing
Endpoints
FDA
generics
Daraprim
Martin Shkreli
Flag link:
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Sandoz
generics
antibiotics
COVID-19
coronaviruses
Flag link:
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Fierce Pharma
Perrigo
Catalent
Teva Pharmaceutical
ProAir HFA
asthma
COPD
generics
Flag link:
FDA Approved 1,014 Generic Drugs in 2019
FDA Approved 1,014 Generic Drugs in 2019
Motley Fool
FDA
generics
drug approvals
Flag link:
FDA Touts Generic Drug Research in 2019
FDA Touts Generic Drug Research in 2019
RAPS.org
generics
R&D
FDA
Flag link:
Former Novartis exec pleads guilty to generic price fixing
Former Novartis exec pleads guilty to generic price fixing
Endpoints
Novartis
Sandoz
price fixing
generics
DOJ
Flag link:
How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are
How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are
Fierce Pharma
China
COVID-19
branded pharma
generics
antivirals
Flag link:
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle
Fierce Pharma
AbbVie
Humira
generics
patents
Flag link:
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Motley Fool
insurers
generics
Catalent
Flag link:
Novartis gives up on Advair generic, leaving Mylan as sole competitor
Novartis gives up on Advair generic, leaving Mylan as sole competitor
BioPharma Dive
Novartis
generics
Advair
Mylan
Flag link:
Pfizer to Market Viagra Through Roman's Telehealth Service
Pfizer to Market Viagra Through Roman's Telehealth Service
Motley Fool
Pfizer
Roman
Ro
generics
Viagra
erectile dysfunction
telehealth
digital health
Greenstone
Flag link:
Blue Cross and Civica Rx Form New Company to Develop Generic Drugs
Blue Cross and Civica Rx Form New Company to Develop Generic Drugs
BioSpace
Blue Cross
Civica Rx
generics
Flag link:
House Committee Quizzes FDA on Complex Generic Drugs
House Committee Quizzes FDA on Complex Generic Drugs
RAPS.org
US Congress
FDA
Stephen Hahn
generics
Flag link:
Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic
Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic
NPR
drug pricing
generics
MS
multiple sclerosis
Flag link:

Pages